Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fahn

Showing results (121-130 of 407) with videos related to

Pageof 41
Sort By:
Neurology|June 1, 1983
Normal erythrocyte uptake of L-DOPA in Parkinson's, Huntington's, and related diseasesD Jiang, A Reches, S Fahn
Harefuah|December 1, 1991
[Botulinum toxin as a powerful new tool in the treatment of focal dystonia]N Giladi, P Greene, S Fahn
Archives of Neurology|July 1, 1971
Acute toxic psychosis from suicidal overdosage of amantadineS Fahn, G Craddock, G Kumin
Advances in Neurology|January 1, 1988
Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystoniaP Greene, H Shale, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Tics in a patient with Parkinson's diseaseH Shale, S Fahn, R Mayeux
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Focal task-specific dystonia induced by peripheral traumaS Frucht, S Fahn, B Ford
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1996
Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopaA Tan, M Salgado, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
Development of resistance to botulinum toxin type A in patients with torticollisP Greene, S Fahn, B Diamond
Advances in Neurology|January 1, 1988
Meige syndrome: primary and secondary formsE Tolosa, J Kulisevsky, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1997
Freezing phenomenon in patients with parkinsonian syndromesN Giladi, R Kao, S Fahn
Pageof 41

Showing results (121-130 of 407) with videos related to

Sort By:
Pageof 41
Neurology|June 1, 1983
Normal erythrocyte uptake of L-DOPA in Parkinson's, Huntington's, and related diseasesD Jiang, A Reches, S Fahn
Harefuah|December 1, 1991
[Botulinum toxin as a powerful new tool in the treatment of focal dystonia]N Giladi, P Greene, S Fahn
Archives of Neurology|July 1, 1971
Acute toxic psychosis from suicidal overdosage of amantadineS Fahn, G Craddock, G Kumin
Advances in Neurology|January 1, 1988
Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystoniaP Greene, H Shale, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Tics in a patient with Parkinson's diseaseH Shale, S Fahn, R Mayeux
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Focal task-specific dystonia induced by peripheral traumaS Frucht, S Fahn, B Ford
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1996
Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopaA Tan, M Salgado, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
Development of resistance to botulinum toxin type A in patients with torticollisP Greene, S Fahn, B Diamond
Advances in Neurology|January 1, 1988
Meige syndrome: primary and secondary formsE Tolosa, J Kulisevsky, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1997
Freezing phenomenon in patients with parkinsonian syndromesN Giladi, R Kao, S Fahn
Pageof 41